Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-004761

CVP, EMEACLA and JAPAC sold 6,640 shares at $83.10 ($551,766)

  • CVP, EMEACLA and JAPAC acquired 6,640 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +6,640 $35.20 $233,706 175,777.78 D
2023-04-06 Sale : show line 2 in the form 10b5-1 −6,640 $83.10 $551,766 169,137.78 D
Open-market sales · 6,640 sh · avg $83.10 · $551,766

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-04-06 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −6,640 $35.20 2023-05-11 6,640 6,640 D
Loading xslF345X04/doc4.xml…